{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:27:27Z","timestamp":1787059647706,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11060-023-04466-5","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T05:01:21Z","timestamp":1698382881000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Preoperative stereotactic radiosurgery as neoadjuvant therapy for resectable brain tumors"],"prefix":"10.1007","volume":"165","author":[{"given":"David","family":"Crompton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Koffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Fekrmandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Lehrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason P.","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Trifiletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"key":"4466_CR1","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/COC.0000000000000866","volume":"44","author":"EJ Lehrer","year":"2021","unstructured":"Lehrer EJ, Stoltzfus KC, Jones BM, Gusani NJ, Walter V, Wang M et al (2021) Trends in diagnosis and treatment of metastatic cancer in the United States. Am J Clin Oncol 44:572\u2013579. https:\/\/doi.org\/10.1097\/COC.0000000000000866","journal-title":"Am J Clin Oncol"},{"key":"4466_CR16","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","volume":"18","author":"A Mahajan","year":"2017","unstructured":"Mahajan A, Ahmed S, McAleer MF, Weinberg JS, Li J, Brown P (2017) Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol 18:1040\u20131048. https:\/\/doi.org\/10.1016\/S1470-2045(17)30414-X","journal-title":"Lancet Oncol"},{"issue":"8","key":"4466_CR2","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","volume":"18","author":"PD Brown","year":"2017","unstructured":"Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC et al (2017) Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (ncctg N107c\/cec.3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol 18(8):1049\u20131060. https:\/\/doi.org\/10.1016\/S1470-2045(17)30441-2","journal-title":"Lancet Oncol"},{"issue":"11","key":"4466_CR3","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","volume":"10","author":"EL Chang","year":"2009","unstructured":"Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10(11):1037\u20131044. https:\/\/doi.org\/10.1016\/S1470-2045(09)70263-3","journal-title":"Lancet Oncol"},{"issue":"8","key":"4466_CR4","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","volume":"18","author":"A Mahajan","year":"2017","unstructured":"Mahajan A, Ahmed S, McAleer MF, Weinberg JS, Li J, Brown P et al (2017) Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol 18(8):1040\u20131048. https:\/\/doi.org\/10.1016\/S1470-2045(17)30414-X. ((2016) 124(4):1018\u201324. 10.3171\/2015.4.JNS1573)","journal-title":"Lancet Oncol"},{"key":"4466_CR15","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1001\/jama.280.17.1485","volume":"280","author":"RA Patchell","year":"1998","unstructured":"Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280:1485\u20131489. https:\/\/doi.org\/10.1001\/jama.280.17.1485","journal-title":"JAMA"},{"issue":"3","key":"4466_CR14","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1016\/j.prro.2021.01.011","volume":"11","author":"DA Roth O'Brien","year":"2021","unstructured":"Roth O\u2019Brien DA, Poppas P, Kaye SM, Mahase SS, An A, Christos PJ et al (2021) Timing of adjuvant fractionated stereotactic radiosurgery affects local control of resected brain metastases. Pract Radiat Oncol 11(3):e267\u2013e275. https:\/\/doi.org\/10.1016\/j.prro.2021.01.011","journal-title":"Pract Radiat Oncol"},{"issue":"3","key":"4466_CR5","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ijrobp.2018.10.038","volume":"103","author":"EJ Lehrer","year":"2019","unstructured":"Lehrer EJ, Peterson JL, Zaorsky NG, Brown PD, Sahgal A, Chiang VL et al (2019) Single versus multifraction stereotactic radiosurgery for large brain metastases: an international meta-analysis of 24 trials. Int J Radiat Oncol Biol Phys 103(3):618\u2013630. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.10.038","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4466_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1748-717X-6-48","volume":"6","author":"G Minniti","year":"2011","unstructured":"Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, Bozzao A et al (2011) Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 6:48. https:\/\/doi.org\/10.1186\/1748-717X-6-48","journal-title":"Radiat Oncol"},{"issue":"2","key":"4466_CR7","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ijrobp.2017.09.047","volume":"100","author":"H Soliman","year":"2018","unstructured":"Soliman H, Ruschin M, Angelov L, Brown PD, Chiang VLS, Kirkpatrick JP et al (2018) Consensus contouring guidelines for postoperative completely resected cavity stereotactic radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 100(2):436\u2013442. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.09.047","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"4466_CR8","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ijrobp.2019.10.002","volume":"106","author":"BE Turner","year":"2020","unstructured":"Turner BE, Prabhu RS, Burri SH, Brown PD, Pollom EL, Milano MT et al (2020) Nodular leptomeningeal disease-a distinct pattern of recurrence after postresection stereotactic radiosurgery for brain metastases: a multi-institutional study of interobserver reliability. Int J Radiat Oncol Biol Phys 106(3):579\u2013586. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.10.002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"4466_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.ijrobp.2013.07.034","volume":"87","author":"B Atalar","year":"2013","unstructured":"Atalar B, Modlin LA, Choi CY, Adler JR, Gibbs IC, Chang SD et al (2013) Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys 87(4):713\u2013718. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.07.034","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4466_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jocn.2017.12.009","volume":"49","author":"PM Foreman","year":"2018","unstructured":"Foreman PM, Jackson BE, Singh KP, Romeo AK, Guthrie BL, Fisher WS et al (2018) Postoperative radiosurgery for the treatment of metastatic brain tumor: evaluation of local failure and leptomeningeal disease. J Clin Neurosci 49:48\u201355. https:\/\/doi.org\/10.1016\/j.jocn.2017.12.009","journal-title":"J Clin Neurosci"},{"issue":"1","key":"4466_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.adro.2019.07.016","volume":"5","author":"SR Marcrom","year":"2020","unstructured":"Marcrom SR, Foreman PM, Colvin TB, McDonald AM, Kirkland RS, Popple RA et al (2020) Focal management of large brain metastases and risk of leptomeningeal disease. Adv Radiat Oncol 5(1):34\u201342. https:\/\/doi.org\/10.1016\/j.adro.2019.07.016","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"4466_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijrobp.2013.09.051","volume":"88","author":"C Brennan","year":"2014","unstructured":"Brennan C, Yang TJ, Hilden P, Zhang Z, Chan K, Yamada Y et al (2014) A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases. Int J Radiat Oncol Biol Phys 88(1):130\u2013136. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.09.051","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4466_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2020.10.JNS201934","volume":"135","author":"DA Roth O'Brien","year":"2021","unstructured":"Roth O\u2019Brien DA, Kaye SM, Poppas PJ, Mahase SS, An A, Christos PJ et al (2021) Time to administration of stereotactic radiosurgery to the cavity after surgery for brain metastases: a real-world analysis. J Neurosurg 135:1\u201311. https:\/\/doi.org\/10.3171\/2020.10.JNS201934","journal-title":"J Neurosurg"},{"key":"4466_CR17","doi-asserted-by":"publisher","first-page":"e507","DOI":"10.1016\/j.prro.2017.04.010","volume":"7","author":"S Lazarev","year":"2017","unstructured":"Lazarev S, McGee H, Moshier E, Ru M, Demicco EG, Gupta V (2017) Preoperative vs postoperative radiation therapy in localized soft tissue sarcoma: nationwide patterns of care and trends in utilization. Pract Radiat Oncol 7:e507\u2013e516. https:\/\/doi.org\/10.1016\/j.prro.2017.04.010","journal-title":"Pract Radiat Oncol"},{"key":"4466_CR18","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"R Sauer","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W, R\u00f6del C, Wittekind C, Fietkau R et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731\u20131740. https:\/\/doi.org\/10.1056\/NEJMoa040694","journal-title":"N Engl J Med"},{"issue":"18 Suppl","key":"4466_CR19","doi-asserted-by":"publisher","first-page":"LBA4002","DOI":"10.1200\/JCO.2018.36.18_suppl.LBA4002","volume":"36","author":"G Van Tienhoven","year":"2018","unstructured":"Van Tienhoven G, Versteijne E, Suker M, Groothuis KBC, Busch OR, Bonsing BA et al (2018) Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC-1): a randomized, controlled, multicenter phase III trial. J Clin Oncol 36(18 Suppl):LBA4002. https:\/\/doi.org\/10.1200\/JCO.2018.36.18_suppl.LBA4002","journal-title":"J Clin Oncol"},{"key":"4466_CR20","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"P van Hagen","year":"2012","unstructured":"van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074\u20132084. https:\/\/doi.org\/10.1056\/NEJMoa1112088","journal-title":"N Engl J Med"},{"key":"4466_CR53","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ijrobp.2015.01.004","volume":"92","author":"AP Kiess","year":"2015","unstructured":"Kiess AP, Wolchok JD, Barker CA, Postow MA, Tabar V, Huse JT, Chan TA, Yamada Y, Beal K (2015) Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment. Int J Radiat Oncol Biol Phys 92:368\u2013375","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4466_CR54","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3171\/2016.9.JNS161585","volume":"127","author":"O Cohen-Inbar","year":"2017","unstructured":"Cohen-Inbar O, Shih HH, Xu Z, Schlesinger D, Sheehan JP (2017) The effect of timing of stereotactic radiosurgery treatment of melanoma brain metastases treated with ipilimumab. J Neurosurg 127:1007\u20131014","journal-title":"J Neurosurg"},{"issue":"10","key":"4466_CR46","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.3390\/ijms19103054","volume":"19","author":"EJ Lehrer","year":"2018","unstructured":"Lehrer EJ et al (2018) Stereotactic radiosurgery and immune checkpoint inhibitors in the management of brain metastases. Int J Mol Sci 19(10):3054","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4466_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/cancers11030294","volume":"11","author":"RA El Shafie","year":"2019","unstructured":"El Shafie RA, Tonndorf-Martini E, Schmitt D, Weber D, Celik A, Dresel T et al (2019) Pre-operative versus post-operative radiosurgery of brain metastases-volumetric and dosimetric impact of treatment sequence and margin concept. Cancers (Basel) 11(3):294","journal-title":"Cancers (Basel)"},{"issue":"2","key":"4466_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1227\/NEU.0000000000001096","volume":"79","author":"KR Patel","year":"2016","unstructured":"Patel KR, Burri SH, Asher AL, Crocker IR, Fraser RW, Zhang C et al (2016) Comparing preoperative with postoperative stereotactic radiosurgery for resectable brain metastases: a multi-institutional analysis. Neurosurgery 79(2):279\u2013285","journal-title":"Neurosurgery"},{"issue":"3","key":"4466_CR23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s11060-016-2334-3","volume":"131","author":"KR Patel","year":"2017","unstructured":"Patel KR, Burri SH, Boselli D, Symanowski JT, Asher AL, Sumrall A et al (2017) Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis. J Neuro-Oncol 131(3):611\u2013618","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"4466_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ijrobp.2017.04.006","volume":"99","author":"RS Prabhu","year":"2017","unstructured":"Prabhu RS, Press RH, Patel KR, Boselli DM, Symanowski JT, Lankford SP et al (2017) Single-fraction stereotactic radiosurgery (SRS) alone versus surgical resection and SRS for large brain metastases: a multi-institutional analysis. Int J Radiat Oncol Biol Phys 99(2):459\u2013467","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4466_CR25","unstructured":"Prabhu RS, Miller KR, Asher AL, Heinzerling JH, Moeller BJ, Lankford SP et al (2018) Preoperative stereotactic radiosurgery before planned resection of brain metastases: updated analysis of efficacy and toxicity of a novel treatment paradigm. J Neurosurg 1\u20138 (this is the largest neoadjuvant SRS series. One-year local control was 80.1%. One-year rates of leptomeningeal disease and radionecrosis were 4.3% and 5.1% respectively. Grade 3 toxicity was 2.6%)"},{"issue":"3","key":"4466_CR52","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s10147-021-02083-8","volume":"27","author":"S Deguchi","year":"2022","unstructured":"Deguchi S, Mitsuya K, Yasui K, Kimura K, Onoe T, Ogawa H, Asakura H, Harada H, Hayashi N (2022) Neoadjuvant fractionated stereotactic radiotherapy followed by piecemeal resection of brain metastasis: a case series of 20 patients. Int J Clin Oncol 27(3):481\u2013487. https:\/\/doi.org\/10.1007\/s10147-021-02083-8. (epub 2021 Nov 18)","journal-title":"Int J Clin Oncol"},{"key":"4466_CR48","doi-asserted-by":"publisher","first-page":"e480","DOI":"10.1016\/j.wneu.2018.08.107","volume":"120","author":"AR Patel","year":"2018","unstructured":"Patel AR, Nedzi L, Lau S, Barnett SL, Mickey BE, Moore W et al (2018) Neoadjuvant stereotactic radiosurgery before surgical resection of cerebral metastases. World Neurosurg 120:e480\u2013e487","journal-title":"World Neurosurg"},{"key":"4466_CR49","doi-asserted-by":"publisher","first-page":"e480","DOI":"10.1016\/j.wneu.2018.08.107","volume":"120","author":"AR Patel","year":"2018","unstructured":"Patel AR, Nedzi L, Lau S, Barnett SL, Mickey BE, Moore W, Bindal S, Wardak Z, Dan T, Timmerman R, Patel TR (2018) Neoadjuvant stereotactic radiosurgery before surgical resection of cerebral metastases. World Neurosurg 120:e480\u2013e487. https:\/\/doi.org\/10.1016\/j.wneu.2018.08.107. (Epub 2018 Aug 24)","journal-title":"World Neurosurg"},{"issue":"12","key":"4466_CR50","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1987","volume":"9","author":"E Vetlova","year":"2017","unstructured":"Vetlova E, Golbin DA, Golanov AV, Potapov AA, Banov SM, Antipina N et al (2017) Preoperative stereotactic radiosurgery of brain metastases: preliminary results. Cureus 9(12):e1987. https:\/\/doi.org\/10.7759\/cureus.1987","journal-title":"Cureus"},{"issue":"suppl_6","key":"4466_CR51","doi-asserted-by":"publisher","first-page":"vi34-vi","DOI":"10.1093\/neuonc\/now212.135","volume":"18","author":"M Bredel","year":"2016","unstructured":"Bredel M, Stewart J (2016) Bmet-35. Rad 1002: phase I dose finding study of pre-operative stereotactic radiosurgery for brain metastases. Neuro-oncol 18(suppl_6):vi34-vi","journal-title":"Neuro-oncol"},{"issue":"5","key":"4466_CR26","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3171\/2014.9.JNS13939","volume":"122","author":"AJ Patel","year":"2015","unstructured":"Patel AJ, Suki D, Hatiboglu MA, Rao VY, Fox BD, Sawaya R (2015) Impact of surgical methodology on the complication rate and functional outcome of patients with a single brain metastasis. J Neurosurg 122(5):1132\u20131143","journal-title":"J Neurosurg"},{"issue":"2","key":"4466_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0360-3016(98)00410-6","volume":"43","author":"M Werner-Wasik","year":"1999","unstructured":"Werner-Wasik M, Rudoler S, Preston PE, Hauck WW, Downes BM, Leeper D et al (1999) Immediate side effects of stereotactic radiotherapy and radiosurgery. Int J Radiat Oncol Biol Phys 43(2):299\u2013304","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"4466_CR28","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459\u2013466","journal-title":"Lancet Oncol"},{"issue":"10","key":"4466_CR29","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996","journal-title":"N Engl J Med"},{"issue":"23","key":"4466_CR30","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","volume":"318","author":"R Stupp","year":"2017","unstructured":"Stupp R, Taillibert S, Kanner A, Read W, Steinberg D, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K, Di Meco F, Lieberman F, Zhu JJ, Stragliotto G, Tran D, Brem S, Hottinger A, Kirson ED, Lavy-Shahaf G, Weinberg U, Kim CY, Paek SH, Nicholas G, Bruna J, Hirte H, Weller M, Palti Y, Hegi ME, Ram Z (2017) Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. JAMA 318(23):2306\u20132316. https:\/\/doi.org\/10.1001\/jama.2017.18718. (Erratum in: JAMA. 2018 May 1;319(17):1824)","journal-title":"JAMA"},{"issue":"4","key":"4466_CR33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC et al (2020) Management of glioblastoma: state of the art and future directions. CA Cancer J Clin 70(4):299\u2013312","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"4466_CR35","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJMoa1308345","volume":"370","author":"OL Chinot","year":"2014","unstructured":"Chinot OL et al (2014) Bevacizumab plus radiotherapy\u2013temozolomide for newly diagnosed glioblastoma. N Engl J Med 370(8):709\u2013722","journal-title":"N Engl J Med"},{"issue":"2","key":"4466_CR32","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3171\/jns.2001.95.2.0190","volume":"95","author":"M Lacroix","year":"2001","unstructured":"Lacroix M et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95(2):190\u2013198","journal-title":"J Neurosurg"},{"issue":"6","key":"4466_CR38","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1200\/JCO.2002.20.6.1635","volume":"20","author":"JL Chan","year":"2002","unstructured":"Chan JL et al (2002) Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol 20(6):1635\u20131642","journal-title":"J Clin Oncol"},{"issue":"3","key":"4466_CR39","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.ijrobp.2020.07.2109","volume":"108","author":"V Gondi","year":"2020","unstructured":"Gondi V et al (2020) Radiotherapy (RT) dose-intensification (DI) using intensity-modulated RT (IMRT) versus standard-dose (SD) RT with temozolomide (TMZ) in newly diagnosed glioblastoma (GBM): preliminary results of NRG Oncology BN001. Int J Radiat Oncol Biol Phys 108(3):S22\u2013S23","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"4466_CR42","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/0360-3016(89)90941-3","volume":"16","author":"KE Wallner","year":"1989","unstructured":"Wallner KE et al (1989) Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16(6):1405\u20131409","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4466_CR34","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s00701-020-04357-y","volume":"162","author":"P Suarez-Meade","year":"2020","unstructured":"Suarez-Meade P et al (2020) Awake vs. asleep motor mapping for glioma resection: a systematic review and meta-analysis. Acta Neurochir 162:1709\u20131720","journal-title":"Acta Neurochir"},{"issue":"1","key":"4466_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1158\/1078-0432.CCR-11-2073","volume":"18","author":"CI Tsien","year":"2012","unstructured":"Tsien CI et al (2012) Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma. Clin Cancer Res 18(1):273\u2013279","journal-title":"Clin Cancer Res"},{"key":"4466_CR40","doi-asserted-by":"crossref","unstructured":"Redmond KJ, Mehta M, Mehta MP (2015) Stereotactic radiosurgery for glioblastoma. Cureus 7(12)","DOI":"10.7759\/cureus.413"},{"issue":"1","key":"4466_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijrobp.2005.05.024","volume":"63","author":"MN Tsao","year":"2005","unstructured":"Tsao MN et al (2005) The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma. Int J Radiat Oncol Biol Phys 63(1):47\u201355","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"4466_CR43","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.ijrobp.2004.04.011","volume":"60","author":"L Souhami","year":"2004","unstructured":"Souhami L et al (2004) Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93\u201305 protocol. Int J Radiat Oncol Biol Phys 60(3):853\u2013860","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"23","key":"4466_CR36","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1056\/NEJM198012043032303","volume":"303","author":"MD Walker","year":"1980","unstructured":"Walker MD et al (1980) Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303(23):1323\u20131329","journal-title":"N Engl J Med"},{"key":"4466_CR37","unstructured":"Leibel SA, Scott CB, Loeffler JS (1994) Contemporary approaches to the treatment of malignant gliomas with radiation therapy. Semin Oncol"},{"issue":"2","key":"4466_CR44","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/biology11020194","volume":"11","author":"EJ Lehrer","year":"2022","unstructured":"Lehrer EJ et al (2022) Preoperative stereotactic radiosurgery for glioblastoma. Biology 11(2):194","journal-title":"Biology"},{"issue":"2","key":"4466_CR45","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ijrobp.2012.12.025","volume":"86","author":"J Zeng","year":"2013","unstructured":"Zeng J et al (2013) Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas. Int J Radiat Oncol Biol Phys 86(2):343\u2013349","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"4466_CR47","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/cancers7010353","volume":"7","author":"F Tommasino","year":"2015","unstructured":"Tommasino F, Durante M (2015) Proton radiobiology. Cancers (Basel) 7(1):353\u2013381","journal-title":"Cancers (Basel)"},{"key":"4466_CR55","doi-asserted-by":"publisher","first-page":"103","DOI":"10.14338\/IJPT-18-00009.1","volume":"5","author":"LM Morton","year":"2019","unstructured":"Morton LM, Ricks-Santi L, West CML, Rosenstein BS (2019) Radiogenomic predictors of adverse effects following charged particle therapy. Int J Part Ther 5:103\u2013113. https:\/\/doi.org\/10.14338\/IJPT-18-00009.1","journal-title":"Int J Part Ther"},{"key":"4466_CR56","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1096\/fj.13-242230","volume":"28","author":"FS Subtil","year":"2014","unstructured":"Subtil FS, Wilhelm J, Bill V et al (2014) Carbon ion radiotherapy of human lung cancer attenuates HIF-1 signaling and acts with considerably enhanced therapeutic efficiency. FASEB J 28:1412\u20131421","journal-title":"FASEB J"},{"issue":"10","key":"4466_CR57","doi-asserted-by":"publisher","first-page":"936","DOI":"10.4065\/73.10.936","volume":"73","author":"SL Stafford","year":"1998","unstructured":"Stafford SL, Perry A, Suman VJ, Meyer FB, Scheithauer BW, Lohse CM, Shaw EG (1998) Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc 73(10):936\u2013942. https:\/\/doi.org\/10.4065\/73.10.936. (PMID: 9787740)","journal-title":"Mayo Clin Proc"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04466-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-023-04466-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04466-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T11:11:39Z","timestamp":1699614699000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-023-04466-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["4466"],"URL":"https:\/\/doi.org\/10.1007\/s11060-023-04466-5","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"8 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Trifiletti reports publishing fees from Springer Inc. as he reported on our Title Page.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Dr. Trifiletti reports clinical trial research support from the Florida Department of Health, Varian Medical Systems, Novocure, and Blue Earth Diagnostics Ltd., publishing fees from Springer Inc., as well as consulting fees from Boston Scientific Corporation. None of the other authors have relevant conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}